EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
EY Corporate Finance offers investment banking services through dedicated teams with a focus on M&A. EY Corporate Finance leverages EY's global network of investment banking professionals to deliver insightful, objective and strategic deal advice on M&A transactions.
Read more -
We can provide you with the detailed guidance you need to navigate the increasingly complex legal environment of the global economy.
Read more
The strategic transaction signifies Medfiles' commitment to enhancing its focus on core services, including Regulatory Affairs, Pharmacovigilance, and Clinical Study services, while ensuring that its laboratory operations continue to flourish under Eurofins' esteemed leadership.
"We believe this move will benefit our clients by providing them with access to an even broader range of high-quality analysis and testing services provided by the broader Eurofins network of laboratories," commented Mirja Savolainen, Managing Director of Eurofins BioPharma Product Testing Finland Oy.
EY Corporate Finance acted as Medfiles’ exclusive financial adviser and EY Law as Medfiles’ legal counsel in the transaction.
Contact details for more information:
Ollipekka Kotkajuuri
Associate Partner, Corporate Finance
ollipekka.kotkajuuri@fi.ey.com
+358 50 464 2599
Tommy Holmström
Director, Transaction Law and Sustainability
+358 40 521 6095
More information can be found on Medfiles press release.